000292595 001__ 292595
000292595 005__ 20241204143044.0
000292595 0247_ $$2doi$$a10.1016/j.colsurfb.2024.114187
000292595 0247_ $$2pmid$$apmid:39243709
000292595 0247_ $$2ISSN$$a0927-7765
000292595 0247_ $$2ISSN$$a1873-4367
000292595 0247_ $$2altmetric$$aaltmetric:166831565
000292595 037__ $$aDKFZ-2024-01825
000292595 041__ $$aEnglish
000292595 082__ $$a540
000292595 1001_ $$aZamborlin, Agata$$b0
000292595 245__ $$aInvasiveness modulation of glioma cells by copper complex-loaded nanoarchitectures.
000292595 260__ $$a[Erscheinungsort nicht ermittelbar]$$bScience Direct$$c2025
000292595 3367_ $$2DRIVER$$aarticle
000292595 3367_ $$2DataCite$$aOutput Types/Journal article
000292595 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1733319023_12765
000292595 3367_ $$2BibTeX$$aARTICLE
000292595 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000292595 3367_ $$00$$2EndNote$$aJournal Article
000292595 500__ $$a#LA:E041#
000292595 520__ $$aAmong the tumors with the highest lethality, gliomas are primary brain tumors associated with common recurrence inclined to metastasize along the neuraxis and occasionally out of the central nervous system. Even though metastasis is the main responsible for death in oncological patients, few dedicated treatments are approved. Therefore, the establishment of effective anti-metastasis agents is the final frontier in cancer research. Interestingly, some copper complexes have demonstrated promising efficacy as antimetastatic agents, but they may cause off-site effects such as the alteration of copper homeostasis in healthy tissues. Thus, the incorporation of copper-based antimetastatic agents in rationally designed nano-architectures can increase the treatment localization reducing the side effects. Here, copper complex loaded hybrid nano-architectures (CuLNAs) are presented and employed to assess the impact of an intracellular copper source on glioma cell invasiveness. The novel CuLNAs are fully characterized and exploited for cell migration modulation in a glioma cell line. The results demonstrate that CuLNAs significantly reduce cell migration without impairing cell proliferation compared to standard gold and copper NAs. A concomitant antimigratory-like regulation of the epithelial-to-mesenchymal transition genes confirmed these results, as the gene encoding for the epithelial protein E-cadherin was upregulated and the other explored mesenchymal genes were downregulated. These findings, together with the intrinsic behaviors of NAs, demonstrate that the inclusion of metal complexes in the nano-architectures is a promising approach for the composition of a family of agents with antimetastatic activity.
000292595 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000292595 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000292595 650_7 $$2Other$$aCopper complex
000292595 650_7 $$2Other$$aEpithelial-to-mesenchymal transition
000292595 650_7 $$2Other$$aGold nanoparticles
000292595 650_7 $$2Other$$aInvasiveness
000292595 650_7 $$2Other$$aMetastasis
000292595 650_7 $$2Other$$aNeuroglioma
000292595 7001_ $$0P:(DE-He78)d06e5bb2d0828caa2be79a51825e84e1$$aPagliari, Francesca$$b1$$udkfz
000292595 7001_ $$aErmini, Maria Laura$$b2
000292595 7001_ $$aFrusca, Valentina$$b3
000292595 7001_ $$0P:(DE-HGF)0$$aGarcía-Calderón, Daniel$$b4
000292595 7001_ $$0P:(DE-He78)62f71d68e658453766d3f349b2b718d4$$aTirinato, Luca$$b5
000292595 7001_ $$aVolante, Stefania$$b6
000292595 7001_ $$aBresciani, Giulio$$b7
000292595 7001_ $$aMarchetti, Fabio$$b8
000292595 7001_ $$0P:(DE-He78)102624aca75cfe987c05343d5fdcf2fe$$aSeco, Joao$$b9$$eLast author$$udkfz
000292595 7001_ $$aVoliani, Valerio$$b10
000292595 773__ $$0PERI:(DE-600)1500523-9$$a10.1016/j.colsurfb.2024.114187$$gVol. 245, p. 114187 -$$p114187$$tColloids and surfaces / B$$v245$$x0927-7765$$y2025
000292595 909CO $$ooai:inrepo02.dkfz.de:292595$$pVDB
000292595 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d06e5bb2d0828caa2be79a51825e84e1$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000292595 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000292595 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)62f71d68e658453766d3f349b2b718d4$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000292595 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)102624aca75cfe987c05343d5fdcf2fe$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000292595 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000292595 9141_ $$y2024
000292595 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCOLLOID SURFACE B : 2022$$d2023-10-21
000292595 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000292595 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000292595 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000292595 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000292595 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000292595 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000292595 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000292595 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000292595 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000292595 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCOLLOID SURFACE B : 2022$$d2023-10-21
000292595 9202_ $$0I:(DE-He78)E041-20160331$$kE041$$lMed. Physik in der Radioonkologie$$x0
000292595 9201_ $$0I:(DE-He78)E041-20160331$$kE041$$lMed. Physik in der Radioonkologie$$x0
000292595 980__ $$ajournal
000292595 980__ $$aVDB
000292595 980__ $$aI:(DE-He78)E041-20160331
000292595 980__ $$aUNRESTRICTED